A 6-month Follow-up Study of Patients With Severe Fever With Thrombocytopenia Syndrome
NCT06011902 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2023-08-25
Summary
This is a multi-center, retrospective clinical study to analyze the clinical features, laboratory indicators, imaging changes, treatment options and long-term prognosis in patients with sever fever with thrombocytopenia syndrome. All hospitalized patients with sever fever with thrombocytopenia diagnosed between 2016 and 2022 were included from the electronic medical record system of 8 centers, and demographics, hospitalization information, clinical information, laboratory or imaging examinations, treatment options, and outcomes were collected.
Conditions
- Severe Fever With Thrombocytopenia Syndrome
Sponsors & Collaborators
-
Tongji Hospital
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-25
- Primary Completion
- 2023-12-31
- Completion
- 2024-03-31
Countries
- China
Study Locations
More Related Trials
-
High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
NCT01356511 ·Status: COMPLETED ·Phase: PHASE4
-
An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP)
NCT02153060 ·Status: COMPLETED ·Phase: PHASE2
-
Sequential rhTPO and Eltrombopag Following Glucocorticoids for Severe Adult ITP
NCT07189910 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker
NCT04003220 ·Status: UNKNOWN
-
Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)
NCT06287567 ·Status: COMPLETED ·Phase: PHASE2
-
Study on the Safety and Efficacy of Cryopreserved Platelets in Hypoproliferative Thrombocytopenic Patients
NCT05067608 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP
NCT01525836 ·Status: COMPLETED ·Phase: PHASE3
-
Longitudinal Cohort Study on Immune Thrombocytopenia Complicated With Acute Ischemic Stroke
NCT07070193 ·Status: NOT_YET_RECRUITING
-
The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP
NCT03377439 ·Status: UNKNOWN
-
Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU Patients
NCT05217719 ·Status: UNKNOWN ·Phase: PHASE4
-
Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children
NCT05520892 ·Status: RECRUITING ·Phase: PHASE4
-
Herombopag + rhTPO in Severe Immune Thrombocytopenia
NCT05328804 ·Status: UNKNOWN ·Phase: PHASE3
-
An Investigation of rhTPO With Different Frequencies in the Management of ITP
NCT02139501 ·Status: COMPLETED ·Phase: PHASE3
-
The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
NCT05281068 ·Status: UNKNOWN ·Phase: PHASE2
-
Prospective Study of Patients With Thrombocytopenia Following HSCT
NCT02487563 ·Status: COMPLETED ·Phase: PHASE3
-
Alteration of Different Immune Parameters in Immune Thrombocytopenia (ITP) Patients Receiving Eltrombopag Treatment
NCT01864512 ·Status: WITHDRAWN
-
Longitudinal Observational Study on Immune Thrombocytopenia
NCT07068425 ·Status: NOT_YET_RECRUITING
-
The International ITP Registry
NCT01970189 ·Status: UNKNOWN
-
High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial
NCT05943691 ·Status: UNKNOWN ·Phase: PHASE2
-
Value of Platelet Indices as Predictive Factor in Thrombocytopenia
NCT05116033 ·Status: UNKNOWN
-
Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia
NCT01719692 ·Status: COMPLETED ·Phase: NA
-
A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts
NCT05583838 ·Status: COMPLETED ·Phase: PHASE4
-
Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP
NCT07057778 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEnia
NCT02707497 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of TPO Receptor Agonists in the Treatment of Elderly ITP Patients
NCT05311930 ·Status: UNKNOWN ·Phase: PHASE4